STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
about
Regulation of STATs by polycystin-1 and their role in polycystic kidney diseaseThe consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domainTargeted therapy for hepatocellular carcinoma: novel agents on the horizonTargeting SH2 domains in breast cancerSTAT inhibitors for cancer therapy.Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells.Development of new N-Arylbenzamides as STAT3 Dimerization Inhibitors.STAT3 association with microtubules and its activation are independent of HDAC6 activitySTAT3 Signaling in Polycystic Kidney DiseaseIL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy.STAT3 regulation of and by microRNAs in development and disease.Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature.Signaling pathways as therapeutic targets in biliary tract cancer.Tracking of STAT3 signaling for anticancer drug-discovery based on localized surface plasmon resonance.Molecular targets of curcumin for cancer therapy: an updated review.Novel STAT 3 inhibitors for treating gastric cancer.Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells in vitro.β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase.Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity.Crocin Suppresses Constitutively Active STAT3 Through Induction of Protein Tyrosine Phosphatase SHP-1.Critical Role of the CXCL10/C-X-C Chemokine Receptor 3 Axis in Promoting Leukocyte Recruitment and Neuronal Injury during Traumatic Optic Neuropathy Induced by Optic Nerve Crush.Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity.MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.
P2860
Q26852136-098BF290-78A1-4D06-926B-2554A1F1F29CQ26861758-536FE871-82C4-464D-BD56-88BBE3DBB819Q27002288-0412EF07-523B-4FEA-894C-FE43C386BF83Q27014674-BF469E2E-C658-4AE3-9257-F90C7A06A00EQ33644206-0090B946-E72F-41B6-8A73-2B9BAB441E57Q34049230-F0771DF4-8B62-4209-803C-16294FDF3CC4Q35000997-39EDB95A-ED67-479F-AB59-3935F84609D0Q35322560-8C3495B4-4144-4FC4-95D8-9C50ECFCE7EAQ36218762-498458EC-CF54-4622-AD5B-3F0FD89474B0Q36608717-EF640D54-81C5-4C26-B142-3C360F4529E0Q36761363-B4ADB6E9-18B7-46B2-8DE9-07E3D2568C4CQ37113973-DADA3559-9DFE-4917-BCDC-C6800BD00B22Q38140887-E2D58971-5BF5-4591-AEA9-D3AD7121D3DAQ38179031-6A31823D-F091-41F5-8396-B5CDD224A0CAQ38747573-F2C4A977-F83B-4C8A-9BB7-0A56C6F89242Q38784547-8C7D3ECE-5E98-4BB5-BC05-1FE7B5AA8C26Q38836822-469B3B04-9429-4DE9-8A04-4FC6C25AA63AQ38870465-C39F7E29-8905-4966-BF57-787A06B5E819Q38962315-410F9E51-1B70-46F3-8CDD-2C72AB6710B9Q38988872-C9E2F6D0-DD01-45A8-A171-03502F183BECQ39024619-7A487C9D-CCF6-48CF-BDCA-197A2B502A0CQ39139874-75E5059D-E7E3-4F5A-BEF8-E7A56634FDD1Q41551997-1E003E4B-6114-4F99-8669-D4B4A4ABB94AQ48125231-0F441967-2B29-46C2-94B4-545A4FFC807DQ51014171-54E0DAA0-CB4E-4064-8B4E-E8166196616BQ51594828-AC2F0622-0E1F-4E7C-B8F9-13680D82F8EBQ54206519-03CBA66D-CE79-4CD5-A987-CF3F1B473CC7Q55637644-1D0BF742-AB2A-4817-B38E-7D86B6DEEC34
P2860
STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
@en
STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
@nl
type
label
STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
@en
STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
@nl
prefLabel
STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
@en
STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
@nl
P2093
P50
P1476
STAT-3 inhibitors: state of the art and new horizons for cancer treatment
@en
P2093
Di Giovanni C
Lavecchia A
Novellino E
P304
P356
10.2174/092986711795843218
P577
2011-01-01T00:00:00Z